American Healthcare REIT Signals Confident Growth Path

American Healthcare REIT, Inc. ((AHR)) has held its Q1 earnings call. Read on for the main highlights of the call.

American Healthcare REIT, Inc. struck an upbeat tone on its latest earnings call, underscoring powerful momentum in its core operations and balance sheet. Management highlighted another quarter of double-digit same-store NOI growth, robust earnings gains, and an expanding acquisition pipeline, while openly acknowledging regulatory headwinds, slower growth in certain segments, and higher G&A tied to stock-based compensation.

Sustained Same-Store NOI Growth

Total portfolio same-store NOI jumped 12.1% in the first quarter of 2026, marking the ninth straight period of double-digit growth. This consistent performance signals durable demand across the company’s healthcare real estate footprint and reinforces the platform’s ability to drive steady cash flow expansion.

Trilogy (ISHC) Outperformance

Trilogy again led the portfolio with same-store NOI growth of 14.5% and same-store occupancy averaging 91.2%, up about 220 basis points from a year earlier. Same-store revenue rose 6.9%, NOI margins topped 20% for the first time since the pandemic, and the quality mix improved to 75.5% of resident days.

SHOP Segment Strength

The senior housing operating portfolio delivered standout results, with same-store NOI up 19.7% and same-store occupancy reaching 88.6%, a gain of roughly 255 basis points year over year. Same-store NOI margin expanded about 215 basis points to 20.6%, underscoring improved profitability as demand and operating efficiency strengthened.

Strong Earnings Growth (NFFO)

Normalized funds from operations reached $0.50 per diluted share in the quarter, a 31.6% jump from $0.38 in the prior year period. This robust earnings growth reflects both operating leverage from rising NOI and contributions from recently completed acquisitions now flowing through the income statement.

Raised 2026 Guidance

The company raised its full-year outlook, now expecting same-store NOI growth between 9% and 12% across the portfolio. NFFO per share guidance was also lifted, with the midpoint implying roughly 20% growth versus 2025 and signaling management’s confidence in continued earnings momentum.

Active, Accretive Acquisition Program

Year to date, American Healthcare REIT has closed $249.2 million of acquisitions, including $162.8 million in the first quarter, and additional deals of about $86.4 million after quarter end. Management stressed a disciplined, operator-first underwriting approach, noting that roughly $950 million of 2025 acquisitions are already accretive to earnings.

Large Awarded Pipeline

The pipeline remains sizable, with more than $650 million in awarded SHOP transactions that management expects largely to close by quarter end, with the remainder following in the third quarter. An in-process development pipeline of about $173.9 million in expected cost, of which approximately $52.4 million is funded, offers further embedded growth.

Improved Balance Sheet and Liquidity

Net debt to annualized EBITDA improved to 3.0 times as of March 31, 2026, down from 3.4 times at year-end, giving the company more flexibility for future investments. Liquidity was enhanced by expanding the unsecured revolver to $800 million, with no borrowings outstanding, and by at-the-market and forward equity arrangements representing significant potential capital.

Conservative SHOP Guidance Despite Outperformance

Despite SHOP’s 19.7% same-store NOI growth in the quarter, management left the full-year SHOP guidance unchanged at 15% to 19%. Leadership cited pacing and seasonality risks, preferring to maintain a cautious stance rather than chase near-term upside after a strong start.

Outpatient Medical and Triple-Net Low Growth

Outpatient medical properties and triple-net lease assets are expected to grow more modestly, with same-store NOI guidance of 0% to 2% and 2% to 3% respectively. These segments provide stability but will likely lag the faster-growing Trilogy and SHOP platforms in terms of incremental contribution.

CMS/Medicare Rate Pressure

Management flagged proposed Medicare rate increases around 2.4% as a potential constraint on reimbursement-driven revenue streams. However, they emphasized that Trilogy intends to offset slower Medicare inflation through a greater private-pay mix and selective Medicare Advantage contracting to sustain margin growth.

RevPOR Deceleration and Same-Store Universe Change

SHOP revenue per occupied room growth appeared to slow, but management attributed this mainly to including more non-stabilized assets that are still ramping occupancy. Tactical decisions such as cutting referral fees by more than 20% are expected to pressure RevPOR temporarily while improving NOI and margins over time.

Increased Competition and Modest Cap-Rate Compression

The company observed more investors entering the SHOP arena and noted cap rates compressing by roughly 25 to 50 basis points over the past year. This shift can tighten initial yields and intensify competition for deals, making disciplined underwriting critical to maintaining accretive acquisition returns.

Higher G&A from Stock-Based Compensation

General and administrative expense guidance rose, largely due to higher stock-based compensation tied to incentive awards for operators and a higher share price. While this lifts reported overhead, management framed it as an investment in alignment and performance that should support long-term value creation.

Forward-Looking Guidance and Outlook

Looking ahead, American Healthcare REIT expects full-year 2026 NFFO per share between about $2.09 and $2.30, or roughly 20% growth over 2025. Combined with projected 9% to 12% same-store NOI gains, a large awarded pipeline, and a strengthened balance sheet, the company’s guidance points to continued growth, tempered by regulatory and competitive constraints.

American Healthcare REIT’s latest call painted a picture of a platform firing on multiple cylinders, with standout growth from Trilogy and SHOP driving strong earnings. While certain segments face slower growth and external pressures, management’s disciplined capital deployment and conservative guidance stance suggest a focus on sustainable, rather than purely short-term, performance.